Masimo Corp - Aug 10, 2023 Form 4 Insider Report for Neuraxis, INC (NRXS)

Role: 10%+ Owner
Signature: /s/ Micah Young, Executive Vice President & Chief Financial Officer, Masimo Corporation
Stock symbol: NRXS
Transactions as of: Aug 10, 2023
Transactions value $: $0
Form type: 4
Date filed: 8/10/2023, 05:16 PM
Previous filing: Aug 8, 2023
Next filing: Aug 11, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	NRXS	Common Stock	Conversion of derivative security		+532K			532K	Aug 10, 2023	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	NRXS	Series A Preferred Stock	Conversion of derivative security	$0	-266K	-100%	$0.00^*	0	Aug 10, 2023	Common Stock	532K		Direct	F1
transaction	NRXS	Pre-Funded Warrant, Series A Preferred Stock (Right to Buy)	Conversion of derivative security	$0	-145K	-100%	$0.00^*	0	Aug 10, 2023	Series A Preferred Stock	145K	$0.00	Direct	F2
transaction	NRXS	Pre-Funded Warrant, Common Stock (Right to Buy)	Conversion of derivative security	$0	+290K		$0.00	290K	Aug 10, 2023	Common Stock	290K	$0.00	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each one share of Series A Preferred Stock converted automatically upon the Issuer's consummation of an initial public offering into two shares of the Issuer's Common Stock. The Series A Preferred Stock had no expiration date.
F2	The Pre-Funded Warrant (the "Warrant") is currently exercisable and has no expiration date. Upon the Issuer's consummation of an initial public offering, the Warrant automatically converted into a warrant exercisable for 289,779 shares of Issuer's Common Stock, and the exercise price was adjusted to be $0.00005 per share of the Issuer's Common Stock.